Literature DB >> 21281814

Ophthalmic pterygium: a stem cell disorder with premalignant features.

Jeanie Chui1, Minas T Coroneo, Lien T Tat, Roger Crouch, Denis Wakefield, Nick Di Girolamo.   

Abstract

Pterygia are common ocular surface lesions thought to originate from limbal stem cells altered by chronic UV exposure. Traditionally regarded as a degenerative condition, pterygia also display tumor-like features, such as a propensity to invade normal tissue and high recurrence rates following resection, and may coexist with secondary premalignant lesions. This study was initiated to determine the rate of concurrent ocular surface diseases in patients with pterygia recruited from the practice of a single surgeon operating in a Sydney metropolitan hospital. One hundred pterygium specimens were histopathologically reviewed and selected cases were immunohistochemically assessed to confirm diagnosis. Along with previously documented typical features including epithelial proliferation, goblet cell hyperplasia, angiogenesis, inflammation, elastosis, stromal plaques, and Bowman's membrane dissolution, we identified five cases of ocular surface squamous neoplasia, six cases of primary acquired melanosis, two compound nevi (one suspect invasive melanoma), and one dermoid-like lesion. In 18 specimens, clusters of basal epithelial cells that coexpressed cytokeratin-15/-19 and p63-α were identified at the head of the pterygium, coinciding with clinical observation of Fuchs' flecks. Our data show that significant preneoplastic lesions may be associated with pterygium and that all excised pterygia should undergo histological examination. The presence of p63-α-positive epithelial cell clusters supports the hypothesis that pterygia develop from limbal epithelial progenitors.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21281814      PMCID: PMC3069871          DOI: 10.1016/j.ajpath.2010.10.037

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  74 in total

Review 1.  The treatment of pterygium.

Authors:  Lawrence W Hirst
Journal:  Surv Ophthalmol       Date:  2003 Mar-Apr       Impact factor: 6.048

2.  Rapid response of refractory ocular surface dysplasia to combination treatment with topical all-trans retinoic acid and interferon alfa-2b.

Authors:  Brent Skippen; Hughie H Tsang; Nagi N Assaad; Minas T Coroneo
Journal:  Arch Ophthalmol       Date:  2010-10

3.  Albedo concentration in the anterior eye: a phenomenon that locates some solar diseases.

Authors:  M T Coroneo
Journal:  Ophthalmic Surg       Date:  1990-01

4.  Differential immunoreactivity of melanocytic lesions of the conjunctiva.

Authors:  N A Sharara; R A Alexander; P J Luthert; J L Hungerford; I A Cree
Journal:  Histopathology       Date:  2001-10       Impact factor: 5.087

Review 5.  Ocular surface squamous neoplasia.

Authors:  G A Lee; L W Hirst
Journal:  Surv Ophthalmol       Date:  1995 May-Jun       Impact factor: 6.048

6.  Elastodysplasia and elastodystrophy as the pathologic bases of ocular pterygia and pinguecula.

Authors:  P Austin; F A Jakobiec; T Iwamoto
Journal:  Ophthalmology       Date:  1983-01       Impact factor: 12.079

7.  Primary acquired melanosis of the conjunctiva.

Authors:  R Folberg; I W McLean; L E Zimmerman
Journal:  Hum Pathol       Date:  1985-02       Impact factor: 3.466

8.  Topical treatment options for conjunctival neoplasms.

Authors:  Jonathan W Kim; David H Abramson
Journal:  Clin Ophthalmol       Date:  2008-09

9.  Distribution of extracellular matrix proteins in pterygia: an immunohistochemical study.

Authors:  Wallid Naib-Majani; Isam Eltohami; Nicolas Wernert; William Watts; Harald Tschesche; Uwe Pleyer; Winrich Breipohl
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-01-29       Impact factor: 3.117

10.  Limbal palisades of Vogt.

Authors:  M F Goldberg; A J Bron
Journal:  Trans Am Ophthalmol Soc       Date:  1982
View more
  85 in total

1.  Triple subconjunctival bevacizumab injection for early corneal recurrent pterygium: one-year follow-up.

Authors:  Angel Nava-Castañeda; Isabel Ulloa-Orozco; Lilia Garnica-Hayashi; Joaquín Hernandez-Orgaz; Maria Carmen Jimenez-Martinez; Yonathan Garfias
Journal:  J Ocul Pharmacol Ther       Date:  2014-11-04       Impact factor: 2.671

2.  Topical dobesilate eye drops for ophthalmic primary pterygium.

Authors:  Pedro Cuevas; Luis A Outeiriño; Javier Angulo; Guillermo Giménez-Gallego
Journal:  BMJ Case Rep       Date:  2012-03-08

3.  Increased expression of nestin in human pterygial epithelium.

Authors:  Dan Wen; Hua Wang; Boon Chin Heng; Hua Liu
Journal:  Int J Ophthalmol       Date:  2013-06-18       Impact factor: 1.779

4.  Effect of porcine chondrocyte-derived extracellular matrix on the pterygium in mouse model.

Authors:  Hye Sook Lee; Ji Hyun Lee; Jae Wook Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-02-23       Impact factor: 3.117

5.  Identification of pterygium-related mRNA expression profiling by microarray analysis.

Authors:  J Liu; X Ding; L Yuan; X Zhang
Journal:  Eye (Lond)       Date:  2017-06-30       Impact factor: 3.775

6.  Unusual large uniocular elastoid and collagenous pinguecula.

Authors:  Frederick A Jakobiec; Alia Rashid; M Sara Bozorg; Reza Dana
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-08       Impact factor: 3.117

7.  Bibliometric analysis and mapping knowledge domain of pterygium: 2000-2019.

Authors:  Yu-Chi Wang; Fang-Kun Zhao; Qian Liu; Zi-Yan Yu; Jing Wang; Jin-Song Zhang
Journal:  Int J Ophthalmol       Date:  2021-06-18       Impact factor: 1.779

8.  What biomarkers explain about pterygium OCT pattern.

Authors:  Sara Lluch; Gemma Julio; Pere Pujol; Dolores Merindano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01       Impact factor: 3.117

9.  Expression of prostaglandin E2 receptor subtypes in human pterygium and normal conjunctiva: immunohistochemical study.

Authors:  Erdem Dinç; Özer Dursun; Banu Yılmaz; Mustafa Vatansever; A Ayça Sarı; Özlem Yıldırım; Ufuk Adıgüzel
Journal:  Int Ophthalmol       Date:  2017-07-10       Impact factor: 2.031

10.  Expression of vascular endothelial growth factor C in human pterygium.

Authors:  Junichi Fukuhara; Satoru Kase; Tsutomu Ohashi; Ryo Ando; Zhenyu Dong; Kousuke Noda; Takeshi Ohguchi; Atsuhiro Kanda; Susumu Ishida
Journal:  Histochem Cell Biol       Date:  2012-08-23       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.